S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

LEXXW Lexaria Bioscience Corporation

0.7471

0.00 (0.00%)

23 Dec 2024 - Closed

Delayed by 15 minutes

Form DEF 14A - Other definitive proxy statements

null

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience Corporation News

Form 8-K - Current report
Thursday 19 December 2024 (5 days ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 18 December 2024 (5 days ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 17 December 2024 (6 days ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 6 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 27 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 27 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 19 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 17 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 3 October 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 24 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 6 September 2024 (4 months ago) • Edgar (US Regulatory)

More Lexaria Bioscience Corporation News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions